Skip to content

Sentinel Lymph Node in Early Ovarian Cancer

Sentinel Lymph Node in Early Ovarian Cancer

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03452982
Acronym
SENTOV
Enrollment
20
Registered
2018-03-02
Start date
2018-03-23
Completion date
2019-08-21
Last updated
2019-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Keywords

SENTINEL LYMPH NODE

Brief summary

This research study evaluates the concordance of the result between two diagnostic tests: Sentinel node and Pelvic-para-aortic lymphadenectomy in patients with ovarian cancer.

Detailed description

The objective of this study is to describe the feasibility of performing the sentinel node technique (Detection rate) in patients with early stage ovarian cancer. With this research study it will be evaluated the concordance of the result between two diagnostic tests: Sentinel node and Pelvic-para-aortic lymphadenectomy in patients with ovarian cancer.

Interventions

Injection of a tracer in the stump of the infundibulo-pelvic ligament and uterus-ovary for sentinel node detection.

Sponsors

Instituto de Investigacion Sanitaria La Fe
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Controlled, prospective, descriptive and not randomized

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Informed consent signed previously to performing any procedure related to the clinical trial. * Patients who are women 18 years of age or older at the moment of the randomization. * Patients with anatomopathological diagnosis of malignant ovarian tumor in a deferred study proposals for staging surgery or patients with suspicious tumor of malignancy who are going to be subjected to exploratory lapaotomy or laparoscopy and operative biopsy, and in the case this is positive, surgery of staging will be performed .

Exclusion criteria

* Informed consent not obtained or withdraw. * Benign result in extemporaneous study * Previous history of vascular surgery in the aorta, cava or pelvic vessels * Previous pelvic or para-aortic lymphadenectomy * Previous lymphoma * Previous abdomino-pelvic tumor * Previous allergic reaction to indocyanine green * Pregnancy / lactation * Severe adherent syndrome

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of performing the sentinel node technique (Detection rate)Intraoperative (day 0)The objective of this study is to describe the feasibility of performing the sentinel node technique (Detection rate) in patients with previous ovarian surgery injecting the tracer in the stump of the infundibulo-pelvic ligament and uterus-ovary for sentinel node detection.

Secondary

MeasureTime frameDescription
Anatomical location of the sentinel node(s)Intraoperative (day 0)Assessed by radiation (99Tc-nanocoloides) and staining with indocyanine green
Number of detected sentinel nodesIntraoperative (day 1)
Characterization of the sample by collecting baseline characteristicsScreening (day 0)Age (years)
Rate of realization of the techniqueIntraoperative (day 0)
Characterization of the sample by collecting intraoperative findingsDay 0Ascites (milliliters)
Characterization of the sample by collecting surgical proceduresDay 0Hysterectomy, adnexectomy, appendectomy, peritonectomy / peritoneal biopsy, omentectomy, lymphadenectomy and blood transfusion (Realized or Unrealized)
Characterization of the sample by collecting tumor markersDay 0Ca 125 and Ca 19.9.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026